Dongzhe Hong on Biosimilar Uptake in the US

A Health Podyssey

Looking to drive meaningful change in the health care ecosystem? Look to the Deloitte Health Equity Institute.

Health Affairs' Editor-in-Chief Alan Weil interviews Dongzhe Hong of Brigham and Women’s Hospital and Harvard University on his recent paper that explores how patient and prescriber factors play into biosimilar uptake in the US.

Order the August 2024 issue of Health Affairs.

Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.